The Department of Justice alleges that former Insys Therapeutics Inc. executives and managers created a reimbursement unit to increase prior authorizations for the company’s fentanyl-based spray Subsys. The government says the individuals then disguised the unit in calls to insurers and pharmacy benefit managers to get them to believe they were getting calls directly from doctors’ offices.
The US Attorney’s Office for the District of Massachusetts announced that six former employees of Insys, including president and CEO...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?